Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

World's first EVER drug shown to work against Alzheimer's developed by scientists

Scientists say the development of the only drug to work against Alzheimer’s is a 'historic moment' - with regulators expected to approve the groundbreaking drug by the New Year

Daily Mirror

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday

Gainers

Benzinga

Stopgap funding measure back on track after Manchin concession on permitting

WASHINGTON — The path to averting a partial government shutdown by Friday night just became a little easier to see, after Senate Democrats said they'd drop a contentious environmental policy rider that had drawn critiques from the right and left.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Starbucks customer stuns with 20 espresso shots order in one drink: ‘Is she ok?’

One Starbucks shot of espresso contains 75 milligrams of caffeine

The Independent UK

Nasdaq Turns Higher; Crude Oil Rises Over 2%

U.S. stocks pared some losses toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

Benzinga

US Stocks Turn Lower; Dow Dips 175 Points

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 175 points on Tuesday.

Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Gainers

Benzinga

Read news from The Economist, FT, and more,
with one subscription

US Stocks Open Higher; Dow Surges 300 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday.

Benzinga

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket

Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.

Benzinga

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday

Gainers

Benzinga

Tesla safety ‘recall’ to be fixed with software update

Tesla CEO insists the recent problem with its car windows is merely a patch. Who is right?

Evening Standard

How does online ADHD testing work? Safe Haven uses FDA-cleared devices without an appointment

We only recommend products we love and that we think you will, too. We may receive a portion of sales from products purchased from this article, which was written by our Commerce team.

Mic

iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26

Bloomberg

Benzinga

Commentary: Prevent a legal Catch-22 that could push thousands of generic drugs off the market

Carvedilol could be the poster child for how to lower drug prices. Since 2007, more than 20 million patients with cardiovascular conditions have enjoyed generic versions of the popular beta-blocker, which cost 2 cents a dose compared with $4.81 for the brand-name product. Patents on the drug Coreg, dating back…

Los Angeles Times

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

Is ketamine the secret to treating depression? Studies reveal its potential

Ketamine is becoming a mainstream in the world of mental health and a slew of new research suggests it has real potential to treat conditions like depression.

Tribune News Service

Hemp-derived delta-8 skirts marijuana laws and raises health concerns

Suzan Kennedy has smoked marijuana, and says her Wisconsin roots mean she can handle booze, so she was not concerned earlier this year when a bartender in St. Paul, Minnesota, described a cocktail with the cannabinoid delta-8 THC as “a little bit potent.”

Boston Herald

‘If not for the Ice Bucket Challenge, we wouldn’t be here’: Cambridge company on the brink of FDA-approved ALS treatment

BOSTON — Eight years after the ALS Ice Bucket Challenge went viral across social media and raised hundreds of millions of dollars for research, a Cambridge company is on the brink of a major breakthrough for ALS patients.

The Guardian - US

Interest in dangerous ‘NyQuil chicken’ videos surged after US agency warning

TikTok searches soared amid flood of media coverage, raising questions about the response to extreme social media challenges

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Ruhaan to participate in FDA selection programme

Sports Bureau

The Guardian - US

‘Forever chemicals’ detected in all umbilical cord blood in 40 studies

Studies collectively examined nearly 30,000 samples over the past five years in ‘disturbing’ findings

WEKU

Here's what the FDA says contributed to the baby formula shortage crisis

The Food and Drug Administration rattled off 15 reasons behind the national baby formula shortage, but couldn't identify a specific person or agency responsible.

Tribune News Service

Formula may be right for infants, but experts warn that toddlers don’t need it

Formulas for toddlers are a burgeoning business in the United States: Sales of the drinks more than doubled in recent years as companies convinced parents that their little ones needed the liquid boost. But many experts warn that these products, designed for children ages 1 to 3, fill no nutritional…

Benzinga

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday

Gainers

The Independent UK

FDA reminds people not to cook chicken in Nyquil after ‘dangerous’ social media trend resurfaces

‘These video challenges, which often target youths, can harm people — and even cause death,’ the agency said

Salon

New report shines light on seafood fraud

In 2019 alone, $2.4 billion worth of imported seafood was identified as illegal, unreported and unregulated

1 … 169 170 171 172

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.